Global Upper Respiratory Tract Infection Treatment Market Report and Forecast 2024-2032

Global Upper Respiratory Tract Infection Treatment Market Outlook

The global upper respiratory tract infection treatment market size attained a value of USD 1.81 billion in 2023. The market is likely to grow at a CAGR of 3.6% during the forecast period of 2024-2032. With this growth rate, the market is anticipated to attain a value of USD 2.48 billion by 2032.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Upper Respiratory Tract Infection Treatment Market: Introduction and Insights

An upper respiratory tract infection (URTI) is an illness, which is the result of an acute infection involving a person’s upper respiratory tract like the nose, sinuses, pharynx, or larynx. The infection commonly includes nasal obstruction, sore throat, tonsillitis, pharyngitis, laryngitis, otitis media, and the common cold. This can be treated using various drugs, targeting disease-causing pathogens like bacteria and viruses.

The signs and symptoms of the condition include fever, cough, runny nose, hoarse voice, fatigue, vomiting, unconsciousness, difficulty in breathing, retractions, especially in children, and stridor, among others. While the symptoms usually get better in one to two weeks, in some cases the condition might get worse if the symptoms do not subside within this timeline. In worst case scenario, the infection might lead to bronchitis or pneumonia.

Upper respiratory tract infection can affect anyone, but some people are more prone to the condition, especially children. Children are at a higher risk of catching the infection since the possibility of transmission is much higher. Children do no follow regular hygiene habits, like washing hands, and are more likely to carry the germs in their hands and put their fingers in their mouth, nose, and/or eyes, enabling the germs to enter the body. Other than children, people with lung or heart disorders are also vulnerable to the condition. Weak immune system also makes people more prone to upper respiratory tract infection.

Upper Respiratory Tract Infection Treatment Market Segmentations

The market can be categorised into segments like type, route of administration, distribution channel, and major regions.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Breakup by Type

• Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) And Nasal Decongestants

• Others

Market Breakup by Route of Administration

• Oral

• Nasal

• Parenteral

Market by Distribution Channel

• Hospital Pharmacies

• Online Pharmacies

• Others

Market Breakup by Region

• North America
  • United States of America
  • Canada
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Others
• Asia Pacific
  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • Others
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Others
• Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Upper Respiratory Tract Infection Treatment Market Analysis

The growing incidence of upper respiratory tract infections, the development of new drugs, and the increasing demand for over-the-counter drugs is aiding the growth of the upper respiratory tract infection treatment market globally. With the advancement in technology and development in the treatment of upper respiratory tract infection, the market is witnessing an increased growth. Further, the growing awareness regarding the treatment and the rising disposable income, especially in emerging economies, are expected to drive the industry growth over the forecast period.

The antibiotics segment, among other types, dominated the global market in 2023, owing to its easy availability and effective results. Region-wise, while North America accounted for the highest share in the market in 2023, the Asia Pacific region is expected to grow at the fastest rate over the forecast period owing to the growing population and increased expenditure on health care services in the region.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Competitive Landscape

The report presents a detailed analysis of the following key players in the global upper respiratory tract infection treatment market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

• GlaxoSmithKline plc

• F. Hoffmann-La Roche Ltd

• Pfizer Inc.

• Cipla Limited

• Lupin Limited

• Merck & Co., Inc.

• Alcon, Inc.

• Teva Pharmaceuticals

• Sandoz, Inc.

Key Highlights of the Report

Upper Respiratory Tract Infection Treatment Market Report Snapshots

Upper Respiratory Tract Infection Treatment Market Size

Upper Respiratory Tract Infection Treatment Market Analysis

Upper Respiratory Tract Infection Treatment Companies